Injectable tissue-engineered soft tissue for tissue augmentation

J Korean Med Sci. 2014 Nov;29 Suppl 3(Suppl 3):S170-5. doi: 10.3346/jkms.2014.29.S3.S170. Epub 2014 Nov 21.

Abstract

Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called "injectable tissue-engineered soft tissue" has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.

Keywords: Cell Therapy; Soft Tissue; Tissue Engineering.

Publication types

  • Review

MeSH terms

  • Adipocytes / transplantation
  • Adipose Tissue / cytology
  • Biocompatible Materials
  • Connective Tissue / surgery*
  • Dermatologic Surgical Procedures / methods*
  • Face
  • Fibroblasts / transplantation
  • Humans
  • Hyaluronic Acid / therapeutic use
  • Injections, Intradermal
  • Mesenchymal Stem Cell Transplantation / methods*
  • Mesenchymal Stem Cells
  • Skin
  • Skin Aging
  • Tissue Engineering / methods*

Substances

  • Biocompatible Materials
  • Hyaluronic Acid